Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06570759 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Time for a Diagnostic Paradigm Shift From STEMI/NSTEMI to OMI/NOMI

Study acronym: DIFOCCULT-3
StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Lead sponsor: Başakşehir Çam & Sakura City Hospital to Başakşehir Çam & Sakura City Hospital Show 4 more changesShow less
    • Trial completed
    • Eligibility criteria expanded, about 10 words
    • Study description expanded, about 13 words
    • Publications: details revised at 8 of 8 entries
  2. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date changed from estimate of Oct 1, 2025 to Sep 1, 2025
    • Study completion date: Oct 1, 2026 to Sep 1, 2026
    • Site details revised at 18 of 18 sites
    v6
  3. Enrollment target: 5000 to 6000
    • Study description shortened, about 88 words
    v5
  4. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 20 to 18
    • Study description expanded, about 21 words
    • Collaborators: 19 to 17
    v4
  5. Site contacts updated at 8 of 20 sitesv3
  6. Study sites revised (20)
    • Collaborators revised (19)
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The investigators hypothesize that occlusion myocardial infarction(MI)/non-occlusion MI approach to MI treatment will better predict acute coronary occlusion on coronary angiography, better limit infarct size, better preserve left ventricular function and result in lower long-term adverse cardiac events (all cause mortality, all cause rehospitalization) compared to standard ST-elevation/non-ST-elevation MI paradigm.
Trial Details
NCT Number NCT06570759
Lead Sponsor Başakşehir Çam & Sakura City Hospital
Collaborators: Ankara Etlik City Hospital, Antalya City Hospital, Bağcılar Training and Research Hospital, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Ataturk University, Eskisehir City Hospital, Kartal Kosuyolu High Speciality Training and Research Hospital, Marmara University Pendik Training and Research Hospital, Istanbul Mehmet Akif Ersoy Educational and Training Hospital, Muğla Sıtkı Koçman University, Necmettin Erbakan University, Eskisehir Osmangazi University, Sirnak State Hospital, Tokat Gaziosmanpasa University, Van Training and Research Hospital, Yuzuncu Yil University, Kutahya Health Sciences University
Conditions
(from sponsor)		 Myocardial Infarction, Myocardial Ischemia, Acute Coronary Syndrome, Diagnosis, Morality
Related terms Acute Coronary Syndrome, Disease, Myocardial Infarction, Myocardial Ischemia
Enrollment 6,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov